Indications, complications and cost of internal jugular catheters in hemodialysed patients: Study of 533 cases;Indications, complications et cout des catheters jugulaires internes chez les hemodialyses: Etude de 533 cas

Tunisie Medicale

Volumn 83, Issue 9, 2005, Pages 519-523

  Ben Hamida, F ^a   M'Hibik, M S ^a   Karoui, C ^a   Abderrahim, E ^a   Kaaroud, H ^a   Beji, S ^a   Zouaghi, K ^a   Barbouche, S ^a   Goucha, R ^a   Hedri, H ^a   El Younsi, F ^a   Ben Abdallah, T ^a   Ben Moussa, F ^a   Kheder, A ^a   Ben Maiz H ^a  

^a CHARLES NICOLLE HOSPITAL   (Tunisia)

Author keywords

Complications; Cost; Hemodialysis; Jugular catheter

Indexed keywords

AMIKACIN; OXACILLIN; POLYURETHAN;

ADOLESCENT; ADULT; AGED; ARTERIOVENOUS FISTULA; ARTICLE; BACTERIOLOGY; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; CAROTID ARTERY INJURY; CATHETER INFECTION; CAUSE OF DEATH; CLINICAL TRIAL; DEVICE REMOVAL; ECONOMIC ASPECT; FEMALE; HEALTH CARE COST; HEMATOMA; HEMODIALYSIS; HUMAN; INTERNAL JUGULAR VEIN; INTRAVENOUS CATHETER; MAJOR CLINICAL STUDY; MALE; PNEUMOTHORAX; SEPTICEMIA; STAPHYLOCOCCUS; TREATMENT INDICATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARTERIOVENOUS SHUNT, SURGICAL; CATHETERIZATION, CENTRAL VENOUS; FEMALE; HEALTH CARE COSTS; HUMANS; JUGULAR VEINS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL DIALYSIS; SEPSIS;

EID: 28544443537     PISSN: 00414131     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Font GF, Dennis V, Quarles LD. Late vascular complications of the subcavian dialysis catheter. Am J Kidney Dis 1986; 7: 225-8.
2. Shapira M. Stern WZ. Hazards of subclavian vein cannulation for central venous pressure monitoring. JAMA 1967; 201: 111-3.
3. Shillinger F, Schillinger D, Montagnac R, Milcent T. Post catheterisation vein stenosis in haemodialysis: comparative angiographic study of 50 subclavian and internal jugular accesses. Nephrol Dial Transplant 1991; 6: 722-4.
4. Churchill DN, Taylor DW, Cook RJ. Canadian hemodialysis Morbidity Study. Am J Kidney Dis 1992; 19: 214-34.
5. Nassar GM, Ayus JC. Infectious complications of the hemodialysis access. Kidney Int 2001; 60: 1-13.
6. Combe CH, Pisoni RL, Port FK, Young EW, Canaud B, Mapes DL, Held PJ. Dialysis outcomes and practice patterns study (DOPPS) : données sur l'utilisation des catheters veineux centraux en hémodialyse chronique. Néphrologie 2001; 22: 379-84.
7. Finielz P, Chuet C, Gendoo Z, Guiserix J. Abord vasculaire temporaire à la Réunion. Néphrologie 1994; 15: 169-70.
8. USRDS: the USRDS dialysis morbidity and mortality study. Wave 2. Am J Kidney Dis 1997; 30 (suppl: 1): 67S-85S.
9. Biffi R, De Braud F, Orsi F, Pozzi S, Arnaldi P, Goldhirsch A, Rotmensz N, Robertson C, Bellomi M, Andreoni B. A randomised prospective trial of central venous ports connected to standard open-ended or Groshong catheters in adult oncology patients. Cancer 2001; 92: 1204-12.
10. Boussen H, Mtaallah M, Dhiab T, Khalfallah S, Jerbi G, Hechiche M, Mezlini A, Rahal K, Ben Ayed F. Evaluation des sites implantables en cancérologie médicale en Tunisie. Etude prospective à propos de 205 cas. Ann Fr Anesth Reanim 2001; 20: 509-13.
11. Boussen H, Jerbi G, Khalfallah S, Hechiche M, Rais H, Mezlini A. Rahal K, Ben Ayed F. Intérêt des voies veineuses centrales (VVC) au long cours en cancérologic médicale : étude prospective à propos de 102 cas. Tunis Med 1998; 76: 120-3.
12. Cimochowski GE, Worley E, Rutherford WE, Sartain J, Blondin J. Superiority of the internal jugular over the subuclavian access for temporary dialysis. Nephron 1990; 54: 154-61.
13. De Meester J, Vanholder R, De Roose J, Ringoir S. Factors and complications affecting catheter and technique survival with permanent single lumen dialysis catheters. Nephrol Dial transplant 1994; 9: 678-83.
14. Bander SJ, Schwab SJ. Central venous angioaccess for hemodialysis and its complications. Semin Dial 1992; 5: 121-8.
15. Abdelkefi A. Achour W, Torjman L, Ladeb S, Ben Othman T, Ben Hassen A, Hsairi M, Ben Abdeladhim A. Infectious complications related to non-tunnelled central venous catheter in immunocompromised patients: prospective study about 210 cases. Ann Fr Anesth Reanim 2003; 22: 773-7.
16. Abdelkefi A, Ladeb S, Ben Othman T, Torjman L, Jeddi R, Ben Hassen A, Ben Abdeladhim A. Indications et complications des voies veineuses centrales en onco-hématologie: à propos de 81 cas. Tunis Med 2000; 78: 641-7.
17. Abdelkefi A, Ben Othman T, Kamoun L, Chelli M, Romdhane NB, Kriaa A, Ladeb S, Torjman L, Lakhal A, Achour W, Ben Hassen A, Hsairi M, Ladeb F, Ben Abdeladhim A. Prevention of venous line-related thrombosis by continuous infusion of low-dose unfractionated heparin, in patients with haemato-oncological disease. A randomised controlled trial. Thromb Haemost 2004; 92: 654-61.
18. Salgado O, Garcia F, Flores J, Herrera J, Rodriguez-Inturbe B. Percutaneous catheterization of the internal jugular vein for hemodialysis: Experience of the hospital Universitario de Maracaibo. Invest Clin 1993; 34: 209-18.
19. Queiros J, Cabrita A, Maximino J, Lobato L, Silva M, Xavier E. Central catheters for hemodialysis : A six months experience of 103 catheters. Nephrology 1994; 15: 113-5.
20. Dittmer ID, Sharps D, Mc Nulty CA, Williams AJ, Banks RA. A prospective study of central venous hemodialysis catheter colonization and peripheral bacteremia. Clin Nephrol 1999; 51: 34-9.
21. Canaud B. Reducing infections associated with central vein catheters. Semin Dial 2000; 13: 206-7.
22. Mermel LA. Prevention of intra-vascular catheter related infections. Ann Med Intern Med 2000; 132: 391-402.
23. Oliver MJ, Callery SM, Thorpe KE, Schwab SJ, Churchill DN. Risk of bacteremia from temporary hemodialysis catheters by site of insertion and duration of use: a prospective study. Kidney Int 2000; 58: 2543-5.
24. Hoen B, Paul Dauphin A, Hestin D, Kessler M. A multicenter prospective study of risk factors for bacteremia in chronic hemodialysis patients. J Am Soc Nephrol 1998; 9: 869-76.
25. Manka, Sexton DJ, Conclon PJ. Catheter related bactermia and outcome of attempted catheter salvage in patient undergoing hemodialysis. Ann Intern Med 1997; 127: 275-280.
26. Powe NR, Jaar B, Furth SL. Septicemia in dialysis patients: incidence, risk factors and prognosis. Kidney Int 1999; 55: 1081-90.
27. Lavigne T, De Almeida N, Meunier O, Petitjean P, Hannedouche T. Résultats préliminaires d'une étude prospective sur les facteurs prédictifs de l'infection liée aux cathéters veineux centraux d'hémodialyse. Néphrologie 2001; 22: 407-8.
28. Nielson J, Ladegoged SD, Kolmos HJ. Dialysis catheter related septicemia: focus on staphylococcus aureus septicemia. Nephrol Dial Transplant 1998; 13: 2847-52.
29. Montagnac R, Schillinger F, Eloy C. Prévention des bactériémies liées aux cathéters veineux centraux en hémodialyse : intérêt d'un soin du site d'insertion par un mélange de rifampicine et protamine. Néphrologie 2003; 24: 159-65.
30. Fourcade J, Mallaval FO, Raffenot D, Mercier D, Maret J, Morel B. Intérêt d'un verrou antibiotique pour la prévention des rércurrences de bactériémies à point de départ des cathéters centraux en hémodialyse chronique. Néphrologie 2001; 22: 457-8.
31. Baquey C. Nouveaux polymères, traitements de surface, matériaux bioactifs : intérêts pour les dispositifs d'accès vasculaire. Néphrologie 2001; 22: 399-402.
32. Carrière C, Marchandin H. Infections liées aux cathéters veineux centraux : diagnostic et définitions. Néphrologie 2001; 22: 433-7.
33. Stephen Paston JM, Michael Soucies William M. Vascular access and increased risk of death among hemodialysis patients. Kidney Int 2002; 62: 620-6.
34. Khan IH, Catto GR, Edward N, Macteod AM. Death during the first 90 days of dialysis: A case control study. Am J Kidney Dis 1995; 25: 276-80.
35. Woods JD, Port FK. The impact of vascular access for haemodialysis patient morbidity and mortality. Nephrol Dial Transplant 1997; 12: 657-9.